Skip to content
★ Sign in to follow
HA

Haim Aviv

Pharmos Corp
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€65k
▼ Sales (0 ops.)
—

Latest filing published 13 Nov 2006 for PHARMOS CORP, €7,403.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Haim Aviv: trading record in brief

Haim Aviv discloses dealings in Pharmos Corp to SEC (Form 4). The record holds 5 filings, for trades running from 9 June 2005 to 9 November 2006.

The open-market record is one-sided, with 5 purchases worth €65k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2006 alone, the filings show 5 purchases and no sales.

Half of the purchases are above €9,250 and half below.

On 13 November 2006 came the latest disclosure, an open-market purchase for €7,403 in Pharmos Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Haim Aviv

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    Chairman and CEOExecutivesPharmos Corp
    9,500 USD0SEC
    5,000 shares@ US$1.90common stockSEC:0001297596-06-000015:0
    Canonical exit: 7 Feb 2007 (T+90)
  • ▲
    Chairman and CEOExecutivesPharmos Corp
    11,700 USD0SEC
    5,000 shares@ US$2.34common stockSEC:0001297596-06-000009:0
    Canonical exit: 5 Sept 2006 (T+90)
  • ▲
    Chairman and CEOExecutivesPharmos Corp
    12,000 USD0SEC
    5,000 shares@ US$2.40common stockSEC:0001331868-06-000004:0
    Canonical exit: 31 Aug 2006 (T+90)
  • ▲
    Chairman and CEOExecutivesPharmos Corp
    10,600 USD0SEC
    5,000 shares@ US$2.12Common StockSEC:0001331868-06-000002:0
    Canonical exit: 21 Aug 2006 (T+90)
  • ▲
    Chairman and CEOExecutivesPharmos Corp
    37,350 USD0SEC
    15,000 shares@ US$2.49Common StockSEC:0001331868-06-000001:0
    Canonical exit: 7 Sept 2005 (T+90)

5 of 5 declarations